<DOC>
	<DOCNO>NCT00071136</DOCNO>
	<brief_summary>This Phase 2 study pemetrexed gemcitabine chemotherapy give every 14 day patient advanced stage non-small cell lung cancer . This treatment patient receive prior chemotherapy treatment lung cancer . The primary goal find tumor get small disappears treatment .</brief_summary>
	<brief_title>Pemetrexed Gemcitabine Patients With Advanced Non-Small Cell Lung Cancer ( NSCLC )</brief_title>
	<detailed_description />
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Gemcitabine</mesh_term>
	<mesh_term>Pemetrexed</mesh_term>
	<criteria>1 . Have diagnosis advance stage nonsmall cell lung cancer . 2 . Are able active home and/or work . 3 . Have receive chemotherapy cancer disease . 4 . Have good organ function ( example , blood work normal ) . 5 . Have complete prior radiation treatment least 4 week ago . 1 . Have treat investigational/research drug within last month . 2 . Have cancer spread brain causing symptom . 3 . Have active infection serious medical condition . 4 . Have second cancer addition nonsmall cell lung cancer . 5 . Can stop take aspirin antiinflammatory agent 58 day .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2007</verification_date>
</DOC>